Efficacy and safety of adjunctive aripiprazole in major depressive disorder in older patients: a pooled subpopulation analysis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Efficacy and safety of adjunctive aripiprazole in major depressive disorder in older patients: a pooled subpopulation analysis

Published:2010-09-09 Issue:6 Volume:26 Page:564-572
ISSN:0885-6230
Container-title:International Journal of Geriatric Psychiatry
language:en
Short-container-title:Int. J. Geriat. Psychiatry

Author:

Steffens David C.,Nelson J. Craig,Eudicone James M.,Andersson Candace,Yang Huyuan,Tran Quynh-Van,Forbes Robert A.,Carlson Berit X.,Berman Robert M.

Publisher

Wiley

Subject

Psychiatry and Mental health,Geriatrics and Gerontology

Reference19 articles.

1. Aripiprazole augmentation in major depressive disorder: a double-blind, placebo-controlled study in patients with inadequate response to antidepressants;Berman;CNS Spectr,2009

2. Berman RM Hazel J Swanink R et al 2008 American Psychiatric Association 161st Annual Meeting

3. The efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder: a multicenter, randomized, double-blind, placebo-controlled study;Berman;J Clin Psychiatr,2007

4. Depression in late life: review and commentary;Blazer;J Gerontol A Biol Sci Med Sci,2003

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Elucidating and unravelling the novel antidepressant mechanism of action for atypical antipsychotics: repurposing the atypical antipsychotics for more comprehensive therapeutic usage;RPS Pharmacy and Pharmacology Reports;2024-06-04

2. Psychopharmacology;The American Psychiatric Association Publishing Textbook of Geriatric Psychiatry;2022-08-09

3. L’utilisation des antidépresseurs dans l’épisode dépressif caractérisé unipolaire du sujet âgé;L'Encéphale;2022-08

4. Guidelines for diagnosis and treatment of depression in older adults: A report from the Japanese Society of mood disorders;Psychiatry and Clinical Neurosciences;2022-04-06

5. Aripiprazole as First-Line Therapy for Late-Life Depression;Journal of Clinical Psychopharmacology;2022-02-21

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3